0 items
Your cart is empty.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
$52.00
This product is available by prescription only
This product does not require a prescription
Out Of Stock
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
Published research involving CJC-1295 No DAC typically investigates:
These investigations are conducted in controlled laboratory systems.
CJC-1295 No DAC is a synthetic peptide analogue studied for its interaction with the growth hormone releasing hormone receptor (GHRH-R). The compound appears in research examining receptor pharmacology and peptide-mediated signaling pathways.
The 5mg format supports receptor binding experiments and comparative signaling assays.
Each batch is verified through analytical testing and COA documentation.
Store as a lyophilized peptide in a cool, dry environment protected from light.
Recommended practices:
Analytical verification includes:
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
High-purity, research-grade peptide synthesis
Analytical testing to verify quality and composition
Consistent batch-to-batch performance
Batch identification on every vial for traceability
Stored and shipped under controlled conditions
Research-grade synthetic tetrapeptide formulated for experimental cellular and longevity-focused research in controlled laboratory environments.
Research-grade dual-peptide formulation combining two synthetic peptides for streamlined laboratory peptide research protocols.
A synthetic 44-amino acid analog of growth hormone-releasing hormone studied for pituitary receptor binding kinetics, GHRH pathway signaling dynamics, and downstream somatotropic axis marker activity in controlled preclinical models.
Research-grade synthetic pentadecapeptide designed for controlled laboratory peptide studies and institutional research programs.
A high-concentration, long-acting GLP-1 receptor agonist studied for incretin pathway receptor pharmacology, downstream cAMP signaling cascade dynamics, and multi-arm metabolic endpoint marker quantification in extended institutional research protocols.
